Insights from the Analysis of the Sepsis Dataset: Understanding the Immune Dynamics and Molecular Pathways in Sepsis

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Wenyan Dai, Juan Liu, Xiaoqiang Li
{"title":"Insights from the Analysis of the Sepsis Dataset: Understanding the Immune Dynamics and Molecular Pathways in Sepsis","authors":"Wenyan Dai,&nbsp;Juan Liu,&nbsp;Xiaoqiang Li","doi":"10.1155/2023/7069469","DOIUrl":null,"url":null,"abstract":"<div>\n <p>Sepsis, a critical medical condition instigated by infections, profoundly alters molecular and cellular immune responses. This study focused on the GSE54514 dataset obtained from the GEO database to uncover the complex gene expression patterns and related pathways in sepsis. A total of 42 genes were found to be expressed differently in septic patients compared to those of healthy individuals. The enrichment analyses of pathways revealed the disruption of natural immune pathways such as toll-like receptor signaling, regulation of actin cytoskeleton, and NOD-like receptor signaling. Through ssGSEA analysis, we revealed a strong association between sepsis and immune cell dynamics, finding significant correlations with HLA-related genes and distinct immune cell populations. Furthermore, genes such as CCL5, CD274, CD3E, and CD8A were linked with pathways, notably the “ribosome” pathway, suggesting potential roles in sepsis-related immune responses. The extensive examination provides fresh perspectives on the gene expression and pathway changes in sepsis, laying the groundwork for upcoming therapeutic interventions and a more profound comprehension of this intricate condition.</p>\n </div>","PeriodicalId":15381,"journal":{"name":"Journal of Clinical Pharmacy and Therapeutics","volume":"2023 1","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2023/7069469","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Pharmacy and Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2023/7069469","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Sepsis, a critical medical condition instigated by infections, profoundly alters molecular and cellular immune responses. This study focused on the GSE54514 dataset obtained from the GEO database to uncover the complex gene expression patterns and related pathways in sepsis. A total of 42 genes were found to be expressed differently in septic patients compared to those of healthy individuals. The enrichment analyses of pathways revealed the disruption of natural immune pathways such as toll-like receptor signaling, regulation of actin cytoskeleton, and NOD-like receptor signaling. Through ssGSEA analysis, we revealed a strong association between sepsis and immune cell dynamics, finding significant correlations with HLA-related genes and distinct immune cell populations. Furthermore, genes such as CCL5, CD274, CD3E, and CD8A were linked with pathways, notably the “ribosome” pathway, suggesting potential roles in sepsis-related immune responses. The extensive examination provides fresh perspectives on the gene expression and pathway changes in sepsis, laying the groundwork for upcoming therapeutic interventions and a more profound comprehension of this intricate condition.

Abstract Image

脓毒症数据集分析的见解:了解脓毒症的免疫动力学和分子途径
脓毒症是一种由感染引起的严重疾病,它深刻地改变了分子和细胞的免疫反应。本研究以GEO数据库中获得的GSE54514数据集为研究对象,揭示脓毒症中复杂的基因表达模式及相关通路。共有42个基因在脓毒症患者中与健康人表达不同。途径的富集分析揭示了自然免疫途径的破坏,如toll样受体信号,肌动蛋白细胞骨架和nod样受体信号的调节。通过ssGSEA分析,我们发现败血症与免疫细胞动力学之间存在很强的相关性,发现与hla相关基因和不同的免疫细胞群存在显著相关性。此外,CCL5、CD274、CD3E和CD8A等基因与途径相关,特别是核糖体途径,提示在败血症相关免疫反应中可能发挥作用。这项广泛的研究为脓毒症的基因表达和通路变化提供了新的视角,为即将到来的治疗干预奠定了基础,并对这一复杂的疾病有了更深刻的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
5.00%
发文量
226
审稿时长
6 months
期刊介绍: The Journal of Clinical Pharmacy and Therapeutics provides a forum for clinicians, pharmacists and pharmacologists to explore and report on issues of common interest. Reports and commentaries on current issues in medical and pharmaceutical practice are encouraged. Papers on evidence-based clinical practice and multidisciplinary collaborative work are particularly welcome. Regular sections in the journal include: editorials, commentaries, reviews (including systematic overviews and meta-analyses), original research and reports, and book reviews. Its scope embraces all aspects of clinical drug development and therapeutics, including: Rational therapeutics Evidence-based practice Safety, cost-effectiveness and clinical efficacy of drugs Drug interactions Clinical impact of drug formulations Pharmacogenetics Personalised, stratified and translational medicine Clinical pharmacokinetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信